Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Everolimus|DRUG: Trastuzumab|DRUG: Paclitaxel
Sponsor: Novartis Pharmaceuticals